CAS: 1802706-04-2
(7S)-N-[[5-(Ethylsulfonyl)-2-pyridinyl]methyl]-6,7-dihydro-7-(1-methylethyl)-6-[[trans-4-(trifluoromethyl)cyclohexyl]methyl]-5H-Pyrr olo[3,4-b]pyridine-3-carboxamide
CAS:1802706-04-2
(7S)-N-[[5-(Ethylsulfonyl)-2-pyridinyl]methyl]-6,7-dihydro-7-(1-methylethyl)-6-[[trans-4-(trifluoromethyl)cyclohexyl]methyl]-5H-Pyrr olo[3,4-b]pyridine-3-carboxamide is a drug candidate for the treatment of lymphocytic leukemia and other cancers. …
Fórmula:
C27H35F3N4O3S
Pureza:
Min. 95%
Peso molecular:
552.65 g/mol
Ref: 3D-CXC70604
Tamanho indefinido | A consultar |
Entrega estimada em Estados Unidos, Terça-feira 11 de Junho de 2024
(7S)-N-[[5-(Ethylsulfonyl)-2-pyridinyl]methyl]-6,7-dihydro-7-(1-methylethyl)-6-[[trans-4-(trifluoromethyl)cyclohexyl]methyl]-5H-Pyrrolo[3,4-b]pyridine-3-carboxamide
CAS:1802706-04-2
Fórmula:
C27H35F3N4O3S
Cor e Forma:
Neat
Peso molecular:
552.652
Ref: TR-E890955
75mg | 22.540,00 € |
Entrega estimada em Estados Unidos, Quinta-feira 11 de Julho de 2024
Vimirogant
CAS:1802706-04-2
Vimirogant is a RORγ inhibitor (Ki: <100 nM).
Fórmula:
C27H35F3N4O3S
Pureza:
98%
Cor e Forma:
Solid
Peso molecular:
552.65
Ref: TM-T16787
25mg | 2.106,00 € | |
50mg | 2.785,00 € | |
100mg | 3.739,00 € |
Entrega estimada em Estados Unidos, Sexta-feira 30 de Agosto de 2024